CN Patent

CN101827856A — 作为胞嘧啶核苷脱氨酶抑制剂的2′-氟-2′-脱氧四氢尿苷

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2010-09-08 · 16y expired

What this patent protects

本发明提供了某些四氢尿苷衍生化合物、含有这种化合物的药物组合物和试剂盒以及制备和使用这种化合物的方法。

USPTO Abstract

本发明提供了某些四氢尿苷衍生化合物、含有这种化合物的药物组合物和试剂盒以及制备和使用这种化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101827856A
Jurisdiction
CN
Classification
—
Expires
2010-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Taiho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.